PEG-2 distearate: CIR Safety Assessment Summary
CIR safety assessment summary for PEG-2 distearate: ingredients reviewed, panel verdict, use concentration context, conditions, and source citation.
PEG-2 distearate appears in a CIR safety assessment covering PEG-2 distearate, PEG-3 distearate, PEG-4 distearate, PEG-6 distearate, PEG-8 distearate, PEG-9 distearate, PEG-12 distearate, PEG-20 distearate, and 4 more. The panel verdict for the report is Safe in cosmetics when formulated to be non-irritating. The CIR Expert Panel concluded that the following ingredients are safe in cosmetics when formulated to be non-irritating. This conclusion supersedes the earlier conclusions issued by the Expert Panel in 1999, 2000, and 2011.
| Field | CIR value |
|---|---|
| Primary ingredient | PEG-2 distearate |
| CIR verdict | Safe in cosmetics when formulated to be non-irritating |
| Report type | Final Amended Report |
| Date | April 7, 2015 |
| CAS numbers | 109-30-8, 52668-97-0, 9005-08-7, 142-20-1, 109-34-2, 68583-52-8, 69278-77-9, 70729-68-9, 6281-04-5, 9005-02-1, 134141-38-1, 52668-97-0, 9005-07-6, 32628-06-1, 61791-01-3 |
| Conditions or carve-outs | When formulated to be non-irritating |
Ingredients Reviewed
The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes PEG-2 distearate, PEG-3 distearate, PEG-4 distearate, PEG-6 distearate, PEG-8 distearate, PEG-9 distearate, PEG-12 distearate, PEG-20 distearate, and 4 more.
Safety Conclusion
The conclusion for PEG-2 distearate should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.
Conditions
When formulated to be non-irritating
Formulation Reading
For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is PEG-2 distearate, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.
The ingredient hub at PEG-2 distearate should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.
Why This Page Exists
CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for PEG-2 distearate, with source details retained at the bottom for audit.
Review Notes
The conservative reading is to keep PEG-2 distearate tied to the exact CIR report listed below. The ingredient family, panel conclusion, date, and any use-condition language belong together. A shorter ingredient-page snippet would lose that context.
This page gives the search-level answer while preserving the source-level caveat: CIR safety language is a panel assessment for cosmetic practices of use, not a universal legal permission across every jurisdiction or product category.
Source
- CIR report: Safety Assessment of PEG Diesters as Used in Cosmetics
- CIR source file: FR689.pdf
- Extraction JSON: Source documentation archived.
- Conclusion page in CIR extraction: 8